Summary
This study addressed the possibility of a unique binding interaction between cocaine and the dopamine transporter as compared with other blockers of dopamine uptake. Cocaine binding sites in a fresh P2 fraction of mouse striatum were labeled with [3H]CFT, a phenyltropane analog of cocaine also known as WIN 35,428, and compared with sites labeled with [3H]mazindol or [3H]GBR 12935. Under the conditions used, homogeneous binding was observed that was inhibited monophasically by cocaine, CFT, and mazindol; the same potencies were observed with the three radioligands. Saturation analysis in the presence and in the absence of unlabeled inhibitor (CFT, mazindol, cocaine) indicated a change in the Kd but not the Bmax, consonant with a competitive mechanism. Tris-HCl reduced the affinity of each radioligand and unlabeled inhibitor without changing the Bmax. N-Ethylmaleimide reduced the binding of all radioligands equally and cocaine offered protection. The dissociation rate of [3H]CFT and [3H]mazindol binding was not affected by the presence of mazindol and CFT, respectively. The Bmax of [3H]CFT and [3H]mazindol binding was the same; the relatively higher value for [3H]GBR 12935 binding in analyses involving varying tritiated GBR 12935 only, was due primarily to an underestimation of the specific activity of [3H]GBR 12935. All results are in agreement with a one-site model in which cocaine, CFT, mazindol, and GBR 12935 share a common binding site in mouse striatum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersen PH (1987) Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J Neurochem 48:1887–1896
Berger P, Janowsky A, Vocci F, Skolnick P, Schweri MM, Paul SM (1985) [3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex. Eur J Pharmacol 107:289–290
Berger P, Gawin F, Kosten TR (1989) Treatment of cocaine abuse with mazindol. Lancet 1:283
Berger P, Elsworth JD, Reith MEA, Tanen D, Roth RH (1990) Complex interaction of cocaine with the dopamine uptake carrier. Eur J Pharmacol 176:251–252
Bonnet JJ, Benmansour S, Vaugeois JM, Costentin J (1988) Ionic requirement for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier. J Neurochem 50:759–765
Bonnet JJ, Benmansour S, Costentin J, Parker EM, Cubeddu LX (1990) Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol. J Pharmacol Exp Ther 253:1206–1214
Calligaro DO, Eldefrawi ME (1988) High affinity stereospecific binding of [3H]cocaine in striatum and its relationship to the dopamine transporter. Membr Biochem 7:87–106
Dubocovich ML, Zahniser NR (1985) Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes. Biochem Pharmacol 34:1137–1144
Fahey MA, Canfield DR, Spealman RD, Madras BK (1989) Comparison of [3H]GBR 12935 and [3H]cocaine binding sites in monkey brain. Soc Neurosci Abstr 15:1090
Grilli M, Sanna E, Hanbauer I (1988) Role of corticostriatal nerve projections in the regulation of binding sites for dopamine uptake blockers. See Neurosci Abstr 14:929
Janowsky A, Berger P, Vocci F, Labarca R, Skolnick P, Paul SM (1986) Characterization of sodium-dependent [3H]GBR-12935 binding in brain: A radioligand for selective labelling of the dopamine transport complex. J Neurochem 46:1272–1276
Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM (1978) Cocaine plasma concentration: relation to physiological subjective effects in humans. Science 202:227–228
Javitch JA, Blaustein RO, Snyder SH (1984) [3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 26:35–44
Humphreys CJ, Levin J, Rudnick G (1988) Antidepressant binding to the porcine and human platelet serotonin transporters. Mol Pharmacol 33:657–663
Kennedy LT, Hanbauer I (1983) Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem 41:172–178
Madras BK, Fahey MA, Bergman J, Canfield DR, Spealman RD (1989a) Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131–141
Madras BK, Spealman RD, Fahey MA, Neumeyer JL, Saha JK, Milius RA (1989b) Cocaine receptors labeled by [3H]2β-carbomethoxy-3-(4-fluorophenyl)tropane. Mol Pharmacol 36: 518–524
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
Niznik HB, Tyndale RE, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W (1990) The dopamine transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. Arch Biochem Biophys 276:424–432
Postma SW, Catterall WA (1984) Inhibition of binding of [3H]batrachotoxinin A 20-α-benzoate to sodium channels by local anesthetics. Mol Pharmacol 25:219–227
Reith MEA, Meisler BH, Sershen H, Lajtha A (1985) Sodium-independent binding of [3H]cocaine in mouse striatum is serotonin related. Brain Res 342:145–148
Reith MEA, Meisler BH, Sershen H, Lajtha A (1986a) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123–1129
Reith MEA, Sershen H, Lajtha A (1986b) Binding sites for [3H]cocaine in mouse striatum and cerebral cortex have different dissociation kinetics. J Neurochem 46:309–312
Reith MEA, Kim SS, Lajtha A (1986c) Structural requirements for cocaine congeners to interact with [3H]bratachotoxinin A20-benzoate binding sites on sodium channels in mouse brain synaptosomes. J Biol Chem 261:7300–7305
Rothman RB, Mele A, Reid AA, Akunne H, Greig N, Thurkauf A, Rice KC, Pert A (1989) Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development. FEBS Lett 257:341–344
Schoemaker H, Pimoule C, Arbilla S, Scatton B, Javoy-Agid F, Langer SZ (1985) Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the striatum and human putamen decrease after dopaminergic denervation and in Parkinson Disease. Naunyn-Schmiedeberg's Arch Pharmacol 329:227–235
Schweri MM, Skolnick P, Rafferty ME, Rice KC, Janowsky AJ, Paul SM (1985) [3H]Threo-(±)-methylphenidate binding to 3–4-dihydroxyphenylethyl-amine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45:1062–1070
Seeman P, Ulpian C, Wreggett KA, Wells JW (1984) Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples. J Neurochem 43:221–235
Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R (1988) A new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 148:427–436
Zimanyi I, Lajtha A, Reith MEA (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn-Schmiedeberg's Arch Pharmacol 340:626–632
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reith, M.E.A., Selmeci, G. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn-Schmiedeberg's Arch Pharmacol 345, 309–318 (1992). https://doi.org/10.1007/BF00168692
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168692